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Cardiovascular diseases (CVD) can induce dysfunction in organ systems by

attenuating normal blood flow. Gonadal steroids are vasoactive hormones, but

their role in contributing to cardiovascular function remains controversial. We

have demonstrated that gonadal steroids can relax coronary arteries by opening
the large-conductance, calcium- and voltage-activated potassium (BKCa) channel
in smooth muscle cells by increasing cyclic nucleotide levels; however, the

signaling pathways involved remain to be elucidated. The purpose of this study
was to identify how phosphorylation (via cAMP- and cGMP-dependent protein

kinases) / dephosphorylation (via phosphoprotein phosphatase 2A, PP2A)

regulates BKCa channel activity in human coronary artery smooth muscle cells
(HCASMC). BKCa channel activity was recorded from single HCASMC

(Lonza/Clonetics) via single-channel and whole-cell patch-clamp. Channel
activity was stimulated by increasing intracellular calcium levels or by

increasing either cAMP or cGMP, but the stimulatory effect was mediated

predominately via the cGMP-dependent protein kinase. In addition, inhibition of
PP2A decreased channel activity. These findings demonstrate that cyclic
nucleotide-dependent vasodilators can regulate arterial function via

phosphorylation of BKCa channels, and that dephosphorylation of the channel

(via PP2A) may play a role in channel activation. We propose that modulation of
BKCa channels via hormone- or drug-induced phosphorylation could be a novel

therapeutic means of helping to lower the risk of CVD in both males and females.
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1. INTRODUCTION
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1.1 Heart Disease

Heart disease has long been a major issue plaguing the American

population. Data on death rates in the US revealed that a death attributable to
cardiovascular disease (CVD) occurs every forty seconds (1). This issue is not

confined to the US as CVD is the leading cause of mortality worldwide. Statistical
analyses of World Health Organization (WHO) and United Nations data show

increased CVD mortality rates in low and middle-income countries in

comparison with high-income countries (2). The establishment of low-to high-

income countries comes from the World Bank’s use of gross national income per
capita to classify countries (3). The US is considered a high-income nation and
follows the trend of declining mortality caused by CVD. However, this does not
erase the need for further improvements in curtailing this disease, as it still
remains the number one cause of death in America (2).

CVD encompasses a multitude of pathophysiological complications

obstructing normal activity of blood distribution throughout the cardiovascular
system. Symptoms such as compromised heart and peripheral vessel function
impact all body systems and include, but are not limited to heart attacks,

ischemic strokes, arrhythmia, and valvular complications (4). Atherosclerosis

and hypertension are two common precursors to CVD that cause restriction of

blood flow (5). Atherosclerosis is the build-up of fat, calcium, and cholesterol to
form plaque in vessels (6). Plaque occludes blood flow by protruding into the

vessel lumen as it grows or by pieces of it breaking off into the lumen (7).
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Hypertension is a condition in which a person’s blood pressure remains above

the accepted value of 139 mmHg systolic and 89 mmHg diastolic. It is important

to note that this accepted value for blood pressure is not definitive for each

person. However, the more one deviates from this value into higher readings, the
more cardiac events are likely to occur (8). According to the American Heart

Association statistical studies, one in three adults above the age of twenty are

living with hypertension. This shows that this condition is still fairly prevalent

even in a society with a declining mortality rate of deaths attributable to CVD
(1).

1.2 Hormones and Heart Disease

The impact of sex hormones on vascular health has been widely accepted,

however, their exact effect on the cardiovascular system is still debatable due to
a wide array of experimental results. The Fogelberg et al. (9) study showed that

inhibition of testosterone aromatization into estrogen promoted atherosclerosis.
Another study performed in orchidectimized mice revealed similar findings of
inhibition of aromatization yielding plaque formation. These findings support

estradiol attenuation of atherosclerotic conditions (10). Observational studies

have also shown that low levels of bioavailable testosterone correlate with lower
aortic atherosclerotic manifestation in men >55 years (11). Sex hormones also

affect vascular tonicity according to experimental data. Estrogen is thought to

lower hypertension by inducing relaxation of vascular smooth muscle in arteries

(12). The growing body of data led many to believe that the introduction of sex
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hormones could yield positive results against CVD.

Negative effects of sex hormones are demonstrated with the use of

hormone replacement therapy (HRT) to supplement low estrogen levels during
menopause. Women have a lower risk for CVD than men prior to menopausal
age. This decline in advantage after menopause can be attributed to the

diminished level of estrogen production in women after this point (13). Women
who experience menopause at an earlier age are also more likely to suffer from
an ischemic stroke. This implies that the sooner the onset of estrogen decline,
the more likely the woman is to develop CVD (14). This along with other data

signifying positive effects of hormones led many to believe that the use of HRT to
raise estrogen levels would help combat CVD. However, when HRT was

introduced in post-menopausal women, their risk for CVD actually worsened.
For example, the Women’s Health Initiative clinical trial employed 16,608

postmenopausal women who were given conjugated equine estrogens showed

that the incidence of CVD increased in comparison to the placebo group. In fact,
the study was cut short due to the strong evidence that estrogen exposure

caused pathologies such as CVD and cancer (15). Sex hormones play a major

factor in cardiovascular health, and must be used within the correct parameters
to be an effective preventative measure for CVD.

Whether sex hormones affect vessels is no longer questioned, but their

mode of action requires more elucidation. Research is now investigating the

exact mechanisms and pathways resulting from sex hormone initiation.
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Numerous studies have shown that the introduction of estrogen above

“physiologic levels” causes vasodilation of vascular smooth muscle (VSM) cells.
In contrast, other studies have shown that estrogen might possibly lead to
vasoconstriction in older women (16) Like estrogen, testosterone is a

vasodilatory hormone (17). The discovery of the effects of sex hormones on

vascular tone and pressure has shed light on a possible complex pathway where
sex hormones could induce vasodilation via a powerful molecular effector

protein, the large-conductance, calcium- and voltage-activated potassium (BKCa)

channel. The purpose of this study will be to investigate molecular signaling
mechanisms whereby sex hormones could produce vasodilation by
opening BKCa channels.
1.3 Hormones and Receptors

The suggested pathways by which sex hormones influence vascular tone

are being established by a growing body of research. Most have singled out the

production of nitric oxide as a major contributing factor to vasodilation, but sex

hormones must prompt a series of biochemical signals before this happens (18).

First, estrogen and testosterone bind to their respective receptors on the VSM

cell. Estrogen can bind to at least two types of estrogen receptors (ER), ERα or

ERβ. In addition, a novel G-protein-coupled ER (GPER) is also expressed in blood
vessels. At present, there is only one known type of androgen receptor for

testosterone and it has a highly conserved sequence (16, 19). Androgen and

estrogen receptors differ in their primary sequence by approximately 56
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percent, but share a similar quaternary structure with both having a ligand-

binding domain made of twelve helices. Sex hormone receptors are found on the
membrane in VSM cells. They can also be located in the cytoplasm, which allows

sex hormones to bind after permeating the cell membrane (19). The diversity in
location of receptors points to the diversity of responses sex hormones are able
to induce.

Estrogen and testosterone are able convert into other steroid derivatives

and still elicit the same vasodilatory response. Aromatase is an enzyme present

in the VSM that functions to aromatize testosterone into estrogen (20). This can
then stimulate vascular signaling via the estrogen transduction pathway. There
has been discussion as to whether the effects of testosterone on vascular tone

and vasodilation are actually due to testosterone itself or to an aromatized form.

Confirmation that testosterone, itself, affects vascular tonicity has been provided
through the use of dihydrotestosterone (DHT). DHT is synthesized from

testosterone via activity of 5a-reductase (21). DHT is incapable of

aromatization, but can also initiate vasodilation (22). This demonstrates that
androgen can cause vasodilation without aromatizing into estrogen. It also

shows how sex hormone-induced vasodilation has multiple molecular effectors.
1.4 Production of Nitric Oxide: The First Messenger

The binding of the hormones to the receptors initiates the activity of

several proteins that stimulate nitric oxide synthase (NOS) (23). ERs and ARs

activate phosphoinositide 3-kinase (PI3) and protein kinase B (Akt), which
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subsequently stimulate activity of NOS via phosphorylation (16, 20). NOS is a

multifunctional enzyme exhibiting both oxygenase and reductase functions (24).
Its oxidation of NADPH can be both coupled and uncoupled. A coupled reaction
occurs when NOS uses all the electrons from NADPH to form monooxygenated

products such as Nω-hydroxy-L-arginine (NOHA) and NO. Uncoupled reactions of

NOS fail to use all of the electrons from NADPH and the excess electrons bind to
molecular oxygen reactive oxygen species (ROS) such as superoxide (25).

Certain isoforms of the enzyme have a greater propensity towards a coupled or

uncoupled reaction. NOS-1 or neuronal NOS (n-NOS) is found in vascular smooth
muscle cells. It has the greatest tendency to produce superoxide under

uncoupled conditions and nitric oxide under coupled conditions (16). In terms of
vasodilation, a coupled condition is favorable because it yields a vasodilatory
product, NO.

Although nNOS produces both NO and superoxide, its production of NO is

important in the vasodilatory pathway as NO is the “first messenger” in the

NO/cGMP/PKG sequence in coupled conditions. NO is produced by nNOS when

L-arginine is converted into L-citruline and is considered to be an endotheliumderived relaxing factor (EDRF) (26, 27). The function of an EDRF is to maintain

tone and resistance in vessels (27). It also activates a series of cascade

phosphorylation steps that amplify the reactions of each enzyme involved (28).

The ability of NO to influence vasodilation is largely dependent on its

concentration. A varying basal concentration level of NO is constitutively
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produced depending on the cell type. Changes in cell function occur when rapid

increases or decreases in NO concentration deviate from the baseline level (24).

A vasodilatory response occurs when the concentration of NO rapidly surpasses

basal levels.

1.5. BKCa Channels and Hypertension

More specifically, the changes occurring in VSM cells are also due to the

NO/cGMP/PKG pathway causing increased large conductance calcium-activated

K+ (BKCa) channel activity and hyperpolarization (29). BKCa channels are found in

all cell types and at greater expression in VSM. A main regulatory mechanism for

these channels occurs by phosphorylation or depolarization (30). Depolarization
and calcium influx into the cell promotes BKCa channel openings. These openings
allow for an efflux of K+ ions and a resulting hyperpolarization of the cell (31).

Hyperpolarization inhibits the cell from a stimulatory depolarization and lowers

the concentration of cytosolic calcium levels. The decreased concentration of
cytosolic calcium results in reduced VSM contraction (29). This series of

reactions creates a standard negative-feedback loop. A muscle cell is stimulated
by an increase in calcium concentration, and this increased calcium

concentration activates BKCa channels which in turn cause a reverse response of

vasodilation. This classic example of negative feedback is important because it is
the body’s aim to protect itself from a hypertensive state in vessels.

The use of electrophysiological methods has elucidated many of the

understood roles of BKCa channels (32-34). Voltage-clamp and patch-clamp

experiments using VSM cells to determine current flow through the membrane
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have revealed a relationship between membrane potential (Em) and vascular

tone. An experiment comparing hypertensive animals to normotensive animals
found that BKCa current was increased in hypertensive animals (35). The

implication of this is that the increased current signified a hyperpolarized

membrane and increased activity of BKCa channels. Another study validated the

increased activity of BKCa by calculating higher levels of open channel probability
(NPo) in hypertensive animals (36). This use of electrophysiology has revealed
that the increase of BKCa channels protects vessels from increased

pressure/tension in a normotensive individual. It also serves as an indicator that
an individual may be hypertensive if the activity is abnormally high. While it is a

seemingly positive protective cellular function, increased level of BKCa channel

activity over extended periods of time serve as an indicator of an individual
suffering with hypertension or CVD (35).
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10pA

500ms

Figure 1: Gonadal steroids open up BKCa channels in coronary artery
smooth muscle cells (CASMC). Channel activity before (control) and 10 min
after exposure to 100 nM 17β-estradiol (A) or testosterone (B). Openings are
upward deflections from baseline (dashed line), +40 mV.

1.6 cGMP/cAMP Act As Second Messengers
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NO production leads to enhanced cGMP synthesis in the VSM. NO-guanylyl

cylcase acts as a catalyst in cGMP’s production from GTP(24). Both cGMP and

cAMP amplify the signal causing dilation of vessels. Cascading pathways using

cGMP and cAMP signaling molecules increase the openings of BKCa channels and
cause dilation (37). Experiments inhibiting NO, but not cGMP, showed that

hyperpolarization still occurred in the cell (38). This isolates the importance of
cGMP/cAMP on vasodilation independent of their precursors.

The direct influence of cGMP and cAMP on VSM still requires clarification

because studies have revealed that they may activate multiple signaling

pathways. cGMP and cAMP act as substrates for PKG and PKA, respectively.

They typically elicit antagonistic responses in cells. These cyclic nucleotides have
the capacity for cross-activation (PKA by cGMP and PKG by cAMP)(39). Crossactivation allows cAMP to play a role in the NO/cGMP/PKG pathway if cAMP

cross-activates PKG. This leaves room for further study of a possible cAMP to
PKG pathway and the resulting implications of such as well.

Establishing an accurate model for mechanisms by which the cyclic

nucleotides interact with the each other and kinases could serve as the key to
understanding the NO/cGMP/PKG pathway in the VSM. Cyclic nucleotides

indirectly affect the concentration of each other by way of phosphodiesterase

(PDE). cAMP increases the level of cGMP indirectly by inhibiting the PDE activity

that hydrolyzes the molecule (37). Inhibiting PDE means an increased amount of

cGMP able to interact in the NO/cGMP/PKG pathway. cAMP concentration
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usually exceeds cGMP by marked amounts at basal levels in all cell types.

However, PKG's strong affinity for cGMP offsets this disproportion to favor cGMP
binding (24). The use of cross-activation becomes even more important in this

regard, because high basal levels of cAMP add to the likelihood that cAMP crossactivates PKG.

Data has also shown that estrogen increases accumulation of cAMP in

mouse granulosa cells or human coronary artery smooth muscle (40, 41). This
shows a direct linkage of sex hormones to second messengers. Further,

testosterone increases cGMP levels in coronary arteries and stimulates the

activity of either PKG or PKA in these same vessels, although the effect on PKG

was predominant (17). In addition, inhibition of PKG activity in coronary artery
smooth muscle attenuates vasodilatory signaling mechanisms stimulated by
either estrogen or testosterone(17, 42). Thus, these studies reveal a direct

linkage of these cyclic nucleotides and their respective kinases to sex hormones
and the possible role they play in this vasodilatory pathway. The increasing
research in this area is showing that there are many ways in which this
mechanism is carried out.

1.7 The role of PKA and PKG

The direct effect of activating or deactivating PKA or PKG is still uncertain.

It has been shown that regulatory binding sites on both PKA and PKG are

structurally similar making cross-activation possible due to similar consensus

sequences (43). Even upon this conclusion, there has been some difficulty in
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determining all of the specific substrates for these kinases because certain
substrates are only phosphorylated in vivo or in vitro and not in both

experimental conditions (39). There is also evidence showing that some PKG

substrates phosphorylated in vivo are actually phosphorylated in vitro as PKA
substrates and vice versa (44).

With much speculation still remaining on the exact pathway of VSM

dilation, a focus should be placed on the role of PKA. The role of PKA in

mediating relaxation of VSM is still controversial. Studies have shown that PKA

promotes VSM hyperpolarization as a result of increased β-adrenoreceptors and
adenylyl cyclase activity(45). Other experiments suggest that BKCa channels are
not substrates for PKA phosphorylation, as BKCa channel activity appeared

unaffected by PKA inhibition (37, 46). Another theory suggests a mechanism in
which PKA phosphorylation subsequently leads to BKCa channel activation (47,

48). It is evident that the role of PKA is far from being understood. The use of

phosphorylation and dephosphorylation to regulate BKCa channels necessitates
the understanding of how these kinases modulate channel activity.
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Figure 2: Proposed mechanism of kinase/phosphatase regulation of BKCa
channels- Binding of sex hormones to receptors elicits a cascade-signaling
pathway with diverse components. Activation of NOS produces the first

messenger, NO, and subsequent second messenger cGMP. Cyclic AMP may also

be produced from adenylyl cyclase. Channels may be phosphorylated by PKA or
PKG, and dephosphorylated by PP2A.

1.8 PP2A Mediates PKA Influence
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As a number of studies have demonstrated that phosphorylation

regulates BKCa channel activity, we hypothesize that PKA not only plays a role in
BKCa channel activity, but that it may do so indirectly through protein

phosphatase 2A (PP2A). PP2A is found ubiquitously in all cells (49). It is a

serine/threonine phosphatase that has a regulatory site for phosphorylation and

methylation. PP2A is a holoenzyme existing as a heterotrimer. This heterotrimer
is composed of a scaffold, catalytic (C), and regulatory (B) subunit (50). More

specifically, the B56δ regulatory subunit of PP2A has been phosphorylated by

PKA in prior in vitro studies (51) validating a possible relationship between the
two in the sex hormone cascade pathway.

Prior research has suggested that inhibition of PP2A leads to increased

BKCa channel activity in mesangial cells (52), thus indicating PP2A as an overall

inhibitory phosphatase. Nonetheless, the role of PP2A in regulating BKCa channel
activity remains controversial, as other studies have suggested that PP2A
activity may open BKCa channels (53, 54). We propose that PP2A

dephosphorylates a stimulatory Pi that the BKCa channel has from PKG

phosphorylation, leading to channel inactivation (48). It is possible that PKA
activates PP2A by phosphorylation, and an activated PP2A removes a

stimulatory Pi that PKG placed on the BKCa channel. With research on the

specific role of PP2A and other intermediates in the mechanism growing yearly,
the specific pathway that sex hormones have in influencing vessel dilation will

continue to be elucidated. This will ultimately yield more possibilities for
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effective drug targeting on specific proteins in this extensive signaling pathway.
1.9 Aims and Hypotheses

Aim # 1: BKCa channels are only one amongst the three types of voltage-sensitive

calcium-activated potassium channels. Therefore, BKCa channel activity must be

distinguished from that of the small-conductance calcium-activated potassium

channels (SKCa) and the intermediate-conductance calcium-activated potassium
channels (IKCa).

Hypothesis 1: If all three calcium-activated potassium channels are present, the
primary channel stimulated by cAMP in HCASMC will be the large-amplitude

BKCa channel with a single-channel conductance of approximately 150 pS(55,

56).

Approach #1:

1. Run Symmetrical and Physiological I/V Curve

Current –Voltage (I-V) relationship curves have been used to determine the
conductance of the channels found in the patch clamp methods (57).

Establishing that the channel inside the patch has a conductance of at least 150

pS will verify that any further experimentation is conducted with BKCa channels
and not IKCa and SKCa channels that exhibit lower conductivity.
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Aim #2: Evidence suggests cAMP-dependent vasodilators increase BKCa channel
activity. The proposed experiments will employ the patch-clamp to establish
whether or not cAMP-dependent vasodilators activate BKCa channels.

Hypothesis #2: The use of cAMP-dependent vasodilators above basal
concentrations will cause an increase in BKCa channel openings.

Previous studies have suggested that forskolin activates the cAMP signaling

pathway, leading to an increase in BKCa channel activity. The suggested
mechanism is that cAMP cross-activates PKG, leading to BKCa activity

increase(37). It is hypothesized that addition of cAMP vasodilators will increase
BKCa channel activity.
Approach #2

1. Measuring the effect of cAMP-dependent vasodilators on VSM cells

Studies have shown that forskolin can increase cAMP concentrations by 6-fold in

coronary arteries(37). In this proposed experiment. forskolin will be introduced
into the cell suspension chamber to establish whether or not cAMP vasodilators
can elicit an effect on BKCa channel activity.
2. Patch Clamp

BKCa channel activity will be recorded before and after addition of cAMP-

dependent vasodilators via the patch clamp, and mean channel activity will be
determined. This will be calculated by recording the product of the number of

channels and the probability that these channels are open (NPo) (# of channels x

open probability). It is anticipated that elevation of cAMP will increase BKCa

17

channel NPo.

Aim #3: Evidence has shown that cAMP works through the NO/cGMP/PKG

pathway through cross-activation(58). Is there a mechanism by which cAMP

activates PKA and causes some effect on BKCa channel activity? If PKA is not an

agonist, is its function on BKCa channels inhibitory of activity or independent?

Hypothesis #3: cAMP does activate PKA similarly to their activation of PKG and
will elicit a response in BKCa channels.

Measuring the response of the BKCa channels when only acted upon by PKA

will provide a clear model for the exact effect PKA has on the BKCa channels. It is
widely accepted that cAMP binds to the regulatory unit of PKA and induces a

cascading effect from the resulting phosphorylation from PKA. However, the role
that PKA has on BKCa channels is still controversial. The forerunning theory is
that PKG acts to open BKCa channels (59). Due to the fact that PKG can be

activated by cAMP and cGMP and induce an effect on BKCa channel activity, it is

proposed that PKA will also affect activity as well. The evidence showing that
only PKG elicits an agonistic response in BKCa channels leaves room for

speculation on the purpose of PKA. PKA could serve a directly inverse function in
BKCa channel activity by actually deactivating the channel.

1. Patch Clamp (Cell-Attached)
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The effect of cAMP-dependent vasodilators (forskolin, or CPT-cAMP) on BKCa

channel activity will be measured in intact (cell-attached) patches on coronary
artery smooth muscle cells before and after pharmacological inhibition of PKA
activity.

Aim #4: If PKA attenuates BKCa channel activity, does this occur indirectly
through action on PP2A?

Hypothesis #4: PKA’s inhibitory effect on BKCa channels occurs indirectly by its

phosphorylation of PP2A and a subsequent dephosphorylation of the BKCa
channels leading to inactivation.

Studies have shown that PKA does not open BKCa channels(37). Other

studies have shown that PP2A functions to inhibit BKCa channels by

dephosphorylation (52). PP2A may be the missing link connecting PKA to BKCa
channels. PKA could act as a regulator of PP2A. PP2A would then function as a
direct regulator of BKCa channels activity. The fact that the B56δ regulatory

subunit of PP2A has been phosphorylated by PKA in prior in vitro studies (51)
validates a possible relationship between the two in the sex hormone cascade
pathway.

Approach #4:

1. Inhibition of PKG and Stimulation of cAMP

PKG will be inactivated by KT5823 to ensure that all BKCa channel activity is
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solely based on PKA 3. Forskolin will also be used to stimulate the production of
cAMP. Since, PKG will be inhibited, all activity due to the presence of cAMP will
be due to PKA and not PKG.
2. Inhibition of PP2A

Pharmacological inhibition of PP2A can be achieved in intact cells by using either
okadaic acid or calyculin A.
3. Patch Clamp

Channel activity will be measured in cell-attached patches before and after PP2A
inhibition. These findings will directly demonstrate either a positive or negative
influence of PP2A on BKCa channel activity.

2. EXPERIMENTAL DESIGN
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The purpose of this study was to elucidate a possible mechanism in which PKA
interacted with BKCa channels. cAMP was first experimentally validated in

influencing BKCa channel activity. Data had already shown cAMP acted as a

known vasodilator and had stimulatory effects on BKCa channel activity (60).

Other prior experimentation had shown that BKCa channel activity might work

independently from PKA. Even if the channels were responsive to PKA activity,
we had to ensure that PKA was sensitive to cAMP in our model first (37). BKCa
channel activity was recorded by using voltage/patch clamp technique before

and after addition of 10 μmol/L forskolin. Forskolin increases the accumulation
of cAMP in the cell and increases activity (37). Recording activity before and

after introduction of forskolin ensured that BKCa channels were responsive and

more importantly; responsive to cAMP increase.

Evidence had shown that cAMP works through the NO/cGMP/PKG

pathway through cross-activation. After establishing that cAMP does alter BKCa
channel activity, cAMP’s use of PKA to alter activity had to be singled out

separately from NO/cGMP(cAMP)/PKG pathway. Is there a mechanism by

which cAMP activates PKA and causes some effect on BKCa channel activity?

3. MATERIALS AND METHODOLOGY
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3.1 Cell Culture Methods

Human vascular smooth muscle cells were obtained from Lonza/Clonetics.

Gelatin was poured into 25 cm2 cell culture flasks and 35mm cell culture dishes
to cover the bottom surface. Each cell culture dish contained four 12 mm glass
cover slips. Gelatin was left in the flasks and dishes for 30 min to allow it to

solidify on the bottom. After 30 minutes, excess gelatin liquid was removed. A
flask containing cells from the generation being split contained media. Media
was decanted off, and cells were washed with 2.5 mL Dulbecco’s Phosphate

Buffer Saline (DPBS (1X)). The DPBS (1X) was decanted off and 1 mL of 0.25%
Trypsin-EDTA (1X) was added and placed in the incubator for 2 min. After the

incubation, cells were viewed under the microscope to ensure they had been
freed from the flask’s gelatinous bottom. Media was added to the solution

containing cells and trypsin. The quantity of media added depended on the

number of flasks and dishes receiving split cells. The total was found by adding 4
mL per flask and 1.5 mL per dish being generated. The solution containing cells,
trypsin, and media was triturated to ensure a uniform concentration. This

solution was split into the flasks and dishes. Each flask received 4.5 mL of split

cells and each dish received 1.5 mL of split cells. Each flask of original cells was

split into three new flasks for the next generation or two new flasks and three 35
mm cell culture dishes containing the cover slips. Cells were stored in an
incubator at 37 ° C and 5% CO2.

3.2 Thawing of Frozen Cultured Cells
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HCASMC were frozen in liquid nitrogen for use at later dates in

experimentation. Upon need, cells were removed from liquid nitrogen and

placed in a water bath at 37 ° C for 2 minutes. 3 mL of media was added to vials
containing 1.5 mL of cells and centrifuged for 5 min at 100 rpm. The

supernatant was pipetted off and an additional 4 mL of media was added. This
solution containing cells and media was placed in a 25 cm2 cell culture flask

already pre-coated with a 2% gelatin solution.

3.3 Primary Cell Isolation

Aortic tissue was excised from male Sprague-Dawley rats in order to

harvest VSM cells. The tissue was placed in HEPES solution and stripped of its

adventitial layer of cells under a dissecting microscope. The tissue was cut into
fragments approximately 1 mm in size and placed in a high K+ solution

containing 140 mmol KCl, 10 mmol MgCl2, .01 mmol CaCl2, 10 mmol HEPES, and
30 mmol glucose. An enzymatic reaction to breakdown the media was created

with the addition of 6 mg papain, 4 mg dithiothreitol (DTT), and 10 mg albumin

dissolved into 5 mL DM solution. Excess high K+ solution was pipetted off the

cells and the cells were added to the DM solution. The cellular DM solution was
placed on a shaker at 70 rpm for 30 min to physically stimulate the enzymatic
reactions. The cellular solution was then removed and triturated. Next, the

solution was placed in a 15 mL centrifuge tube and spun in the centrifuge for 10
min at 1000 rpm. Cells in the solution formed a pellet at the bottom of the

centrifuge tube. Two or three drops of cellular solution were placed on

microscope for electrophysiological patch clamping experiments. Remaining
cellular solution was stored at 4oC and kept up to 24 hrs.
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3.4 Patch Clamp Apparatus

A.

Patch Microscope

Amplifier

Oscilliscope

Microelectrode
Manipulator

Analog/Digital (AD)
Converter

FIGURE 3: Patch Clamp Apparatus- The patch clamp microscope received
voltage input from the amplifier via the microelectrode in a closed circuit system.
This signal fed back to the A/D converter that converted the analog channel
activity into a digital signal that the computer program could interpret. The
microelectrode manipulator was used to position the microelectrode in
proximity to the cells for patching. The oscilloscope was used to observe the
generation of a seal before patching.
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B.

Microelectrode

Cell Recording Chamber

FIGURE 4: Cell Suspension Chamber- The
microelectrode was positioned close to the cell
inside of the cell suspension chamber using the
microelectrode manipulator. The
microelectrode contained a metal wire to allow
conduction from the amplifier to the patch
located inside its tip.
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Figure 5: Generating a Mega-Ohm Seal- Microelectrodes were polished to

have a 2-5 MΩ resistance prior to forming a giga-ohm seal. The figure shows a

pipette with a calculated 2 MΩ resistance. As shown, the pipette has not formed
a giga-ohm seal, therefore current is still flowing at a recordable value.
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Figure 6: Seal Formation- A giga-ohm seal has been formed. The high level of

resistance formed in the seal prevents current flow and is shown by a horizontal
line on the oscilloscope.

3.5a Generating a Giga-Ohm Seal
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Microelectrodes were generated by pulling 1.50 mm capillary glass tubes

with the Sutter Instrument P-2000 microelectrode puller and polished by heat. A

polished pipette was determined by having a 2-5 MΩ resistance calculated from
the TDS 2002 Two-Channel Digital Storage Oscilloscope recording.

Microelectrodes were filled with pipette solution and attached to the MP Sutter
Instruments-285micro manipulator. The pipette solution varied depending on

experimental conditions. In single channel-cell attached/inside-out conditions,

the microelectrode was filled with a normal Ringer solution. In whole cell

conditions, the microelectrode was filled with high K+ solution. The

microelectrode was lowered into the recording chamber filled with cellular
suspension using the micromanipulator. Once the microelectrode was in

positioned in close proximity to the desired cell, suction was applied by mouth

through a 1 mL syringe. To determine that a giga-ohm seal had been established,

the AxoPatch 200B amplifier from Axon Instruments was set to ‘seal test’ and the
oscilloscope reading showed a maximum resistance and no current flow. The
prevention of current flow due to high resistance was represented by a

horizontal line on the oscilloscope, and verified that a giga-ohm seal had been
established.

BATH
High K=
140 K+

A.

B.

C.

FIGURE 7: Patch Clamp Configurations
(A) Under single-channel cell-attached conditions, the pipette was filled with Ringer solution containing 5mM of K+ in the form of KCl in

order to ensure recording of physiologic cellular conditions for the flow of ions between the pipette and a single channel. (B) Under single-

channel inside-out conditions, the pipette was dislodged from the rest of the cell with the seal still intact to a portion of the membrane. The
current flow of ions was recorded solely between the channel in the patch and the High K+ bath in the recording chamber. (C) Whole cell

recording occurred by rupturing the membrane inside of the patch while the rest of the cell was still attached. The flow of ions through the
all channels outside of the patch was recorded. To ensure that physiologic conditions occurred here, Ringer pipette solution was added to
the bath in the recording chamber.
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3.5b Single-Channel Cell-Attached
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For cell-attached patches, a few drops of cell suspension were placed in the

recording chamber. Several drops of high K+ solution were added to the cell

suspension in the recording chamber as well. The microelectrode was filled with
Ringer pipette solution and placed on the micromanipulator. Once a giga-ohm

seal had been achieved, the ‘seal test’ parameters were removed. With the use of
a high K+ bath in the recording chamber, the voltage across the patch was

clamped at 0 mV. Currents were filtered at 2kHz and digitized at 10 kHz. Control
and experimental groups were clamped at both 0 mV and 40 mV. Addition of

forskolin, KT 5720, forskolin + KT 5720, okadaic acid, okadaic acid + KT 5720,
chlorophenylthio-cAMP (CPT-cAMP), CPT-cAMP + KT 5720, sodium

nitroprusside (SNP) or tetraethylammonimum (TEA) composed the

experimental groups. The drugs were administered to the cell bath after a

control recording of the channels was recorded at 0mV and 40 mV. After 10

minutes in the bath, the patch was clamped at 40 mV and activity was recorded.

Administration of the second drug occurred after the recording of the first drug.

Recording of the subsequent response of the second drug occurred after 10 min.
3.5c Single Channel Inside-Out

A few drops of cell suspension were placed in the recording chamber.

Several drops of high K+ solution were then added to the cell suspension in the

recording chamber. The microelectrode was filled with Ringer pipette solution
and placed on the micromanipulator. Once a giga-ohm seal had been achieved,

the ‘seal test’ parameters were removed. With the cell still attached to the
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microelectrode, the micromanipulator was used to raise the microelectrode out
of the bath and immediately lowered back into the bath. The membrane still

maintained a giga-ohm seal with the microelectrode, but the rest of the cell was
now detached from the microelectrode. With the use of high K+ bath in the

recording chamber, the voltage across the patch was clamped at 0 mV. Currents
were filtered at 2kHz and digitized at 10 kHz. Control and experimental groups
were clamped at both 0 mV and 40 mV. In the case of the TEA experimental

groups, the recordings occurred directly after drug administration.
3.5d Whole- Cell

A few drops of cell suspension were placed in the recording chamber.

Several drops of normal Ringer solution were added to the cell suspension in the
recording chamber as well. The microelectrode was filled with a high K+ solution

with added amphotericin-B and placed on the micromanipulator. Once a giga-

ohm cell was produced, perforations in the cell membrane were produced from
amphotericin-B and visualized on the oscilloscope. After perforations were

generated, the ‘seal test’ parameters were removed. Currents were filtered at

2kHz and digitized at 10 kHz. Control and experimental groups were clamped at
and recorded at voltage ranging from -50 mV to 40 mV in 10 mV increments.

3.6 Measurement BKCa Channel Activity
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BKCa channel activity was quantified by calculation of the mean open channel

probability (NPo). The NPo values were generated by Clampfit 9.2 and Origin 2.0

computer software. The recordings of BKCa channel activity clamped at a range

of voltages in 10 mV increments were also analyzed in Clampfit 9.2 to access the

current amplitudes. The current amplitudes were then plotted in Microsoft Excel
to calculate the current-voltage (I-V) curves tested in a physiological K+ ionic

condition.

Patch Clamp Solutions Table
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Solution

mM / L

High Potassium Bath (High K+)

140 KCl
10 MgCl2
0.1 CaCl2
10 HEPES
30 Glucose
140 NaCl
5 KCl
1 MgCl2
2 CaCl2
10 HEPES

Dissociation Medium (DM)

Normal Ringer

110 NaCl
5 KCl
10 HEPES
10 NHCO3
0.5 KH2PO4
10 Glucose
2 MgCl2
0.16 CaCl2

4. RESULTS
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4.1 Forskolin Increases Whole-Cell Current in HCASMC

Whole-cell patch-clamp recording was used to determine the effect of cAMPdependent vasodilators on HCASMC. Recordings were obtained at 10 mV

intervals in a range from -50 mV to +40 mV (Figure 8). Control group activity

was recorded before 10 μM forskolin was added to the cell suspension chamber
for experimental group recording. Generation of a current- voltage (I-V)

relationship curve quantitatively calculated the relationship of outward current

to voltage in the cell. As the clamped voltage increased, the current subsequently
increased revealing a positive correlation in both the control and experimental

groups. The addition of forskolin increased the outward current of the whole cell
in the experimental group compared to the control group when clamped at
voltages above -20 mV. At voltages under -20 mV, the control group had a
greater outward current.
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FIGURE 8: A cAMP-dependent vasodilator increases
outward current in HCASMC. Forskolin (10 μM, 10 min)

increased outward current in HCASMC. A) Current traces recorded
before (red) and 10 min after (blue) addition of forskolin (+40mV). B)
Complete current (I)-voltage (V) relationship before (red) and after
(blue) forskolin.
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4.2 BKCa Channels are expressed in HCASMC

Although cAMP generation increased outward currents, the identification

of the channel(s) involved cannot be determined from whole-cell studies.

Therefore we identified the specific channel stimulated by cAMP at the

molecular level by performing single-channel patch-clamp studies. Activity in

both cell-attached and inside-out patch configurations confirmed the presence of
BKCa channels in HCASMC when clamped at +40 mV. Recordings of the patch

clamp traces noted distinguishable channel openings and closings (FIGURE 9A,
9B). Channel openings were observable in physiological concentrations of

calcium (10-7 M) where channels were patched in cell-attached configurations.
Exposure to higher concentrations of calcium (10-4M) in the high K+ solution

showed a 1,000 fold (p< .001; n=3 ) increase in channel activity. This increased

exposure was accomplished by detaching the channel in the patch from the rest

of the cell so that the channel could now be exposed to the higher concentration
of calcium in the cell suspension chamber. The amplitude of the channel

openings was approximately 10 pA at +40mV.

Channel conductance was calculated to distinguish the presence of of BKCa

from IKCa and SKCa channels. The calculated channel conductance was 152.4 ± 7

pS (n= 4 patches) using the slope from an I-V relationship plot. The voltages for
this relationship were clamped with the cells being in physiological K+
concentration (FIGURE 9C).
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Addition of 1-5 mM of TEA to the cell suspension chamber in an inside-out

configuration clamped at 0 mV yielded a 100-fold decrease in BKCa channel

activity. The NPO for the control and experimental recordings were 0.9130 and
0.0079, respectively. The patch clamp traces validated the data with an

observable decrease in BKCa channel activity after the addition of TEA (10A,
10B).
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BKCa Channels Are Expressed in HCASMC
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Figure 9: BKCa channel identification in HCASMC. (A)

Channel activity recorded in the same HCASMC patch (+40mV).
Upper trace: cell-attached patch (normal calcium; 10-7 M calcium).
Lower trace: inside-out patch (100μM calcium). (B) On average,
raising calcium increased channel activity by > 1000-fold (bar graph;
*p<0.001; n=3). (C) Channel conductance is ~150 pS in physiological
[K+] (n=4 patches).
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TEA Inhibits BKCa Channel Activity

A
4 pA

B
1

0.9

BKCa Channel Inhibition
0.9130

0.8

NPo

0.7
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0.3
0.2
0.1

0

0.0079
1
Control

2
TEA

FIGURE 10: TEA inhibits BKCa channel activity in inside-out patch. (A)
Left trace: High level of BKCa channel activity with distinguishable
openings and closings (0 mV). Right Trace: Decreased level of BKCa
channel activity after addition of 10 μM TEA. (B) NPO decreased 100-fold
after addition of TEA. (n=1)

4.3 Elevating cAMP Increases BKCa Channel Activity in Cell-Attached Patches
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Increasing the level of cAMP in HCASMC increased the level of BKCa

channel activity. Recordings of cell-attached patches at +40 mV before (control)
and 10 min after addition of 10 µM forskolin were collected. The traces showed
observable increase with forskolin(FIGURE 11). The NPo of the control and

forskolin group were 0.0525 and 0.0778, respectively (FIGURE 12) (n=1).

Recordings after the addition of chlorophenythio-cAMP showed a similar trend.
CPT-cAMP is a membrane-permeable derivative of cAMP that can influence

channels still attached to the rest of the cell. Addition of either cAMP-stimulating
drugs caused an NPo of 0.0689, while the control NPo was 0.0523 (FIGURE 12).
The trace comparing channel activity before (control) and 30 min after the

addition of 100µM CPT-cAMP showed an even more distinguishable difference
in channel activity than when the control was compared to forskolin. This data
suggests a positive correlation between stimulation of cAMP and BKCa channel

activity.
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Effect of cAMP on BKCa Channel Activity

10pA
500ms

FIGURE 11: cAMP-dependent vasodilators increase BKCa
activity in HCASMC. Upper traces: Recordings from a cell-attached patch

(+40mV) before and 10 min after addition of 10mM forskolin. Lower traces:
Recordings from another cell-attached patch (+40mV) before and 30 min
after addition of 100mM chlorophenylthio (CPT)-cAMP, a membranepermeable derivative.Channel openings are upward deflections from baseline.
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cAMP Effect on BKCa Channel Activity
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FIGURE 12: Addition of Forskolin Increases BKCa Channel Activity.
Calculations of NPo from cells patched before (control) and 10 min after addition of 10 μM
forskolin. Additions of forskolin increased NPo from 0.0525 to 0.0778

4.4 BKCa Channel Activation is Mediated Via PKG, But Independent of PKA
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BKCa activity increased using 10 μM forskolin in cell-attached patches.

Forskolin increased activity, so that any possible inhibition of activity would be

observable on the trace. A trace was recorded 10 min after forskolin was added
followed by the addition of the PKA inhibitor (300 nM KT 5720). The trace of

the control showed observable channel openings for what appeared to be one
channel present in the patch (FIGURE 13A). Forskolin addition increased the

channel openings in the trace to a distinguishable level of second channel

openings approximately 20 pA above baseline. The subsequent addition of KT
5720 showed no observable increase in channel activity from that of the

forskolin addition suggesting BKCa channels may not be a target of PKA activity.

The NPO values for the control, forskolin addition, and subsequent KT 5720

addition were 0.0523, 0.0689, and 0.0675, respectively (FIGURE 14A). This

validated the trace showing an increase in channel activity with the addition, but
no change after the addition of KT 5720.

Comparing the traces before (control) and 10 min after the addition of a

PKG stimulator sodium nitroprusside (SNP), an NO donor, showed an observable
increase in BKCa channel activity suggesting that channel activity increases with

activation of PKG. Stimulation of PKG activity with SNP showed an increase from
control activity with NPO values increasing from 0.0102 to 0.1310. Activation of

PKG increased BKCa channel activity 10-fold (FIGURE 14B).
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Figure 13: Inhibition of PKA does not affect BKCa channel activity, but
activation of PKG opens channels. (A) Channel activity recorded in the same
HCASMC patch (+40mV) before (control), 10 min after 10 μM forskolin, and 20 min
after addition of 300nM KT5720 (PKA inhibitor). Inhibition of PKA did not affect
channel activity. (B) Channel activity recorded in the same HCASMC patch (+40mV)
before (control) and 12 min after 10 μM sodium nitroprusside (SNP; PKG activator).
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FIGURE 14: BKCa Channel Activity increased with PKG
activity and is independent of PKA activity. (A) After

stimulating control activity with 10 μM forskolin, inhibition of PKA with
KT 5720 showed now change in channel activity. (B) Stimulating PKG
with 10 μM SNP increased channel activity 10 fold.
4.5 Inhibiting Channel Dephosphorylation Decreases BKCa Channel Activity

Patch-clamp traces using cell-attached methods validated that BKCa
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channel activity was stimulated with the addition of 100 µM CPT-cAMP for 30
min when clamped at +40 mV. Addition of CPT-cAMP to the control increased
the NPO 100-fold from 0.0025 to 0.3176 (FIGURE 15B). In FIGURE 15A, two

levels of BKCa channel activity can be distinguished by the openings at

approximately 10 pA and 20 pA amplitudes. Subsequent addition of PP2A

inhibitor (100 nM okadaic acid) for another 15 min showed a definitive decrease

in channel activity now with only one channel being activated at an amplitude of
approximately 10 pA. The subsequent addition of OA dropped the NPO back
down again 50-fold from 0.3176 to 0.0064. The graph showed significant

increase in channel activity with CPT-cAMP and decrease with OA (*p<0.05)
(n=3).
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Figure 15: Okadaic acid reverses cAMP-stimulated BKCa
channel activity in HCASMC.(A) Representative recordings from a cell-

attached patch (+40mV) HCASMC treated with 100mM CPT-cAMP (30 min) and
45 min after 100nM okadaic acid (OA). Channel openings are upward
deflections from the baseline (closed) state (dashed line). (B) Summary graph
demonstrating significant (*p<0.05) channel stimulation by cAMP with
subsequent inhibition by OA (n=3), which is a selective inhibitor for PP2A.

5. DISCUSSION
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The importance of BKCa channels in vasodilation has been confirmed by

many studies, however the mechanism behind this important regulatory effector
still needs elucidation. It is apparent that after gonadal steriods bind to their
receptors there is subsequent activation of PI3, Akt kinases, and nitric oxide

synthase (61, 62). Nonetheless, we still do not understand the precise role of the
cyclic nucleotide-dependent kinases activated subsequent to cyclic nucleotide

generation. Working with the common precept that PKG activates BKCa channels,

we constructed a mechanism in which PKG activates the channels via

phosphorylation. Prior research shows that PKG and PKA exhibit antagonistic

responses, leading to a proposal that PKA phosphorylation inhibited channel
activity (39). The belief that PKA phosphorylation works with PP2A

dephosphorylation stems from prior data reporting PP2A as a possible substrate
for PKA (51) and data showing PP2A inhibition increasing BKCa activity. This
evidence supported our initial hypothesis of indirect PKA and direct PP2A
inhibition of BKCa via phosphorylation and dephosphorylation.

To examine the role of the cyclic nucleotide-dependent kinases on the

channels, we first established that BKCa channels were actually expressed in

HCASMC. The BKCa channel is known to be depolarization-activated and also

calcium-dependent (31). The currents recorded in whole-cell experiments

increased with voltage, so it verified a voltage-dependency of the channels in
HCASMC. Subsequent experiments on inside-out patches revealed that
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increasing calcium at the cytoplasmic surface of the channel stimulated activity.
Stimulation of cAMP production increased whole-cell outward currents in

HCASMC. Interestingly, however, we noted that cAMP did not appear to increase
outward currents at negative (i.e., < -20mV) voltages. This finding could be

attributed to the fact that BKCa channels are voltage-dependent and require a

depolarized cell to activate. The lower the voltage, the less likely BKCa channels

are to be active. In contrast, as the cell was increasingly depolarized (> -20mV)

forskolin had more influence on BKCa activity. These findings are consistent with
a model where BKCa channels carry the majority of outward current in HCASMC,

are deplarization-activated, and highly sensitive to stimulation by cAMP. Thus,
we propose that cAMP is an important signaling molecule in the signaling
cascade governing BKCa channel activity.

However, these data alone could not verify that the increase of outward

current on the cellular level was solely due to BKCa channel response. To verify

this increase was due mainly to calcium-activated channels, we assessed the

response of BKCa channels on a molecular level. Single channels in cell-attached
patches are functioning at physiological levels of Ca2+ (10-7 M), and this basal

level of BKCa activity was recorded. After excising the patch into an inside-out

configuration to expose these channels to high Ca2+ concentration (10-4 M), the

activity increased 1,000-fold. These findings verified the expression of calcium-

activated potassium channels in HCASMC, and further suggested that the original
increase in the outward current on the cellular level was due primarily to
activity of calcium-activated channels.
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Smooth muscle cells also express other calcium-activated K channels: IKCa

and SKCa channels. Establishing that the channels were calcium-sensitive was

important, but did not differentiate between the types of these K channels; i.e.,
BKCa , IKCa and/or SKCa. Generation of a single-channel I-V relationship in

physiological potassium gradients allowed us to calculate the conductance of the
calcium-activated channel to be an average of 152.4 ± 7 pS. Experimentation has
shown that the conductance of BKCa, IKCa, and SKCa channels under these

conditions is ~150 pS, ~39 pS, and ~10 pS, respectively. (57). Our calculated

conductance value agreed with the accepted value and validated that the activity
observed in the traces was due primarily to BKCa channels.

Measuring the open-channel amplitude and exposing an inside-out patch to

TEA also confirmed the presence of BKCa channels in HCASMC. The recorded

amplitude of the channel openings was approximately 10 pA at +40mV. This was
in the characteristic range for BKCa channels found in other studies involving

myocytes from both porcine and human tissues when clamped at this voltage

(63, 64). Channels were clamped at +40 mV because prior experimentation from
our lab and other studies have shown that BKCa channels are clearly

distinguishable at this voltage (37, 65). Lastly, when the channel was exposed to
TEA in an inside-out patch, the channel activity decreased 100-fold. TEA is a

known BKCa channel blocker with higher selectivity for BKCa channels at lower

concentrations, i.e., <1 mM (66). Thus, our experiments have defined that the
channel responsible for the majority of outward current in HCASMC is

depolarization-activated, highly calcium-dependent, sensitive to inhibition by

TEA, and has a large molecular conductance. Therefore, we have identified this
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protein as the BKCa channel known to be highly expressed in coronary artery
smooth muscle cells.

We had observed that forskolin increased whole-cell outward currents in

HCASMC. However, the cell-attached patch revealed the effect of this cAMP-

dependent vasodilator on BKCa channels. The NPO increased after the addition of
forskolin, which confirmed BKCa channel sensitivity to cAMP. The NPO increased

even greater with the addition of CPT-cAMP. The variation in the BKCa response
between forskolin and CPT-cAMP could be attributed to the fact that forskolin
directly activates adenylyl cyclase and indirectly increases cAMP, while CPTcAMP is a membrane-permeable derivative of cAMP and serves to directly

increase the cyclic nucleotide. These experiments clearly demonstrated that

increasing intracellular cAMP levels stimulates BKCa channel activity in HCASMC.
Testing for the role of cyclic nucleotide-dependent kinases suggested that

PKG stimulates BKCa channel activity while PKA activity may not affect channel
activity. Addition of a PKG stimulator (SNP) increased NPO 10-fold, while

addition of a PKA inhibitor (KT 5720) showed no observable change in activity.
The data validated the common belief that PKG stimulates BKCa channels, but

still leaves many things to question about the role of PKA. The decreased channel
activity following addition of the PP2A inhibitor (okadaic acid) suggests that

PP2A may play a stimulatory role rather than inhibitory. The data showed that
PKG and PP2A both play a role in activating the channel, and perhaps they do

this in conjunction. Instead of PP2A working with PKA to dephosphorylate a
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stimulatory phosphate off of the channel, PP2A may function following

activation by PKG to dephosphorylate an inhibitory phosphate from the channel.
In other words, PP2A activity may mediate a more indirect stimulatory effect of
PKG on BKCa channel activity, instead of requiring direct PKG-dependent

phosphorylation of the channel protein. To our knowledge, this is the first time
this mechanism has been demonstrated in coronary arteries (particularly in

human coronary artery smooth muscle). However, support for this mechanism is
derived from similar studies done in mesenteric microvascular smooth muscle
cells (53). Nonetheless, the role of PP2A may be more complicated, as

researchers found that PP2A activation could inhibit BKCa channel activity in

mesangial smooth muscle cells (67). Although these data differ from our original
proposed function of PP2A, it now sheds light on possible variability in PP2A
function depending on cell type and localization.

Our study adds to an increasing effort to identify the signaling pathways

regulating BKCa channel activity. The activity of BKCa channels is regulated by
their phosphorylation by cyclic nucleotide-dependent kinases and

dephosphorylation by protein phosphatases. We concluded that PKG stimulates
the channels. Other studies also support this finding. Fukao et al. (1999)

reported similar findings as SNP also increased BKCa channel activity in cloned

BKCa channels from canine colonic smooth muscle cells (68). More importantly,
the addition of PKG and ATP to the cytosolic surface of BKCa channels increased

the NPo 3.2-fold in cloned colonic smooth muscle cells (37, 69). Another study

found that BKCa channels have a strong consensus site for PKG phosphorylation
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near the COOH terminal end. The channels also have 11 possible sites for PKA
phosphorylation, however, these are all weaker consensus sites (70). The

presence of a PKG consensus site in this study confirms that the BKCa channel is a
likely substrate for PKG-dependent phosphorylation. The evidence of weak

consensus PKA phosphorylation sites gives cause to further investigate its role
as our data suggests that channels are actually unaffected by PKA activity. The

role of PP2A also needs further investigation. Imig et al. (54) inhibited PP2A in

renal artery smooth muscle cells and observed decreased BKCa channel activity.
This was congruent to results from our experiments in coronary artery smooth
muscle cells. Further, White et al. (46) reported that okadaic acid inhibited

cGMP-stimulated BKCa channel activity in neuroendocrine cells. Thus, there is
evidence from both vascular and non-vascular cells that PP2A mediates a
stimulatory effect on BKCa channels. In contrast, other studies report an

inhibitory role for PP2A. For example, Sansom et al. (1997) reported that the

inhibition of PP2A increased BKCa channel activity in mesangial cells (52). Taken
together, the contradictory results with these kinases and phosphatase confirm

the need for increased investigation into defining the signaling mechanism

whereby phosphorylation / dephosphorylation regulates BKCa channel activity.
This study investigated the molecular signaling mechanisms of BKCa

channels that mediate coronary artery relaxation. The BKCa channel is a highly-

expressed protein in HCASMC, and we found activity of this channel dominates
membrane electrical activity in these cells. These channels provide a powerful

repolarizing influence that closes voltage-dependent calcium channels, thereby

54

leading to HCASMC relaxation and coronary artery vasodilation. Given the

important role played by BKCa channels, integration of our data for potential

clinical use is most important. It is critical to determine the exact vasodilatory

mechanism involving BKCa channel activation because this will provide strong

implications for these mechanisms serving as novel pharmacological targets to
relieving myocardial ischemia or hypertension. Hypertension accompanies

multiple disease states, such as diabetes, hypoxia, obesity, and CVD (71-73) As

these diseases are spread amongst all demographics, finding a drug therapy to
target hypertension, one of the major symptoms, could greatly increase the
health of an entire population.

There is increasing evidence that hypertension-related diseases exhibit

alterations in molecular signaling. One study showed that increased levels of

phosphorylated-Akt (p-Akt) were linked to pulmonary hypoxia, and that the use

of an anti-hypoxic drug, baicalin, increased BKCa channel activity (71). Research
showed that NOS activity was increased in obese rats in comparison to control
(74) Another study linked higher BKCa channel NPO and lower channel

conductance to rats with streptozotocin-induced diabetes in their thoracic aortic
smooth muscle cells (75). A wide variety of physiological and disease states are
influenced by activity of BKCa channels and their regulatory molecules (e.g., Akt,
NOS). Understanding the cascading pathways that determine their function will
help clinicians and pharmacuetical companies more effectively target the many
diseases that exist due to BKCa channel function and dysfunction.
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FIGURE 16: Modified BKCa mechanism with stimulatory PP2A. Both PKG
and PP2A elicited increased BKCa response. In this modified mechanism, PKG
phosphorylates PP2A. This activates PP2A to remove an inhibitory Pi. The
source of the Pi still needs to be determined. PKA could be the kinase
responsible for the addition of the Pi.

6. CONCLUSION AND FURTHER STUDIES
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In conclusion, these findings are the first to provide evidence suggesting

that dephosphorylation by PP2A opens BKCa channels in human coronary artery

smooth muscle cells. The data also links gonadal steroids, cyclic nucleotides, and
BKCa channel activity. We propose PP2A to be an exciting novel therapeutic

target to promote coronary artery vasodilation and thereby reduce ischemic

injury. Given the increased use of gonadal steroids, particularly in older women
and men, it would be of subtantial health benefit to understand how these

powerful hormones can modify cardiovascular function. An important goal
would be to isolate the signaling mechanisms of gonadal steroids in blood

vessels from the endocrine effects of these hormones, thus helping to potentially
maximize their therapeutic use while minimizing unwanted or dangerous side
effects.

Further objectives for this research would call for running more trials to

establish the potential clinical significance of the data. I also propose testing for

the influence of PP2A working in conjunction with PKG on BKCa channel activity.
He (2000) showed that PKG may not directly activate channels leading to the
belief that there is an intermediate molecule involved in activation (76).

Experimentation on whether or not PP2A is actually a substrate for PKG would
clearly support their relationship. Finally determining the level of PP2A in

various types smooth muscle tissues would shed light on the why its function
has shown varying effects depending on the cell type.
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